APP

Skip to main content

Case Comprehensive Cancer Center

5 Questions… with celebrated pediatric oncologist Peter de Blank
In June, Peter de Blank, assistant professor in pediatric oncology and hematology, added a new accolade to his collection—the inaugural Francis S. Collins Award to research neurofibromatosis (NF). He was one of the first two researchers to receive the prestigious honor sponsored by the…
Grant backs nursing program to increase patient participation in clinical cancer trials
APP medical and nursing school researchers hope to drastically increase the number of qualified cancer patients who participate in clinical trials, a critical step in testing and developing new treatments and preventions. For various reasons—including a lack of…
CWRU, UH announce collaborative fundraising initiative for Adolescent and Young Adult cancer
Announcement comes as Char and Chuck Fowler make third major gift to help defeat the disease, inspiring an anonymous donor to commit $5 million as well Leaders from APP and University Hospitals Monday announced a new collaborative fundraising effort focused on Adolescent…
CTSC/Coulter grant awarded to biomedical engineering, medicine faculty
Anant Madabhushi, associate professor in the Department of Biomedical Engineering, and investigators at the Case Comprehensive Cancer Center, including Lyndsay Harris, professor of medicine-hematology and oncology, and Hannah Gilmore, assistant professor of pathology, were awarded a…
Researchers discover pathway of protein that helps cancer cells survive
Case Comprehensive Cancer Center researchers' discovery could lead to better treatment outcomes A team of researchers from Case Western Reserve School of Medicine has discovered how the cancer-related protein Bcl-2 signals cancer cells to live longer. The breakthrough emerged when the scientists…
Research team discovers key mechanisms to inhibit triple negative breast cancers
Findings could lead to life-saving treatments to fight tumor metastasis A team of researchers from Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly “triple negative” breast cancers (TNBC). These tumors are…
CWRU, Cleveland Clinic and UH launch venture to advance analysis of medical data
Renowned genetic scientist to lead collaboration to use lessons from big data to benefit individual patients, broader communities APP, Cleveland Clinic and University Hospitals announced the launch of the Institute of Computational Biology, an innovative venture…
CWRU researchers use nanotechnology to fight aggressive cancers
Researchers at APP have received two grants totaling nearly $1.7 million to build nanoparticles that seek and destroy metastases too small to be detected with current technologies. They are targeting aggressive cancers that persist through traditional chemotherapy and…
School of Medicine scientist wins National Institutes of Health New Innovator Award
Grant will allow exploration of new methods designed to treat cancer Derek Taylor, assistant professor in the Department of Pharmacology at the APP School of Medicine, has been awarded the prestigious New Innovator Award by the National Institutes of Health (NIH). The…
New book chronicles latest advances in cancer gene therapy
The field of gene therapy promises to dramatically transform the treatment of disease, as well as fundamentally change the delivery of health care in the 21st century. A new book provides a comprehensive review of the field of gene-based therapeutics in an expanded third edition textbook that…